Efficacy of Aspergillus galactomannan-directed preemptive therapy for the prevention of invasive aspergillosis in organ transplant recipients

Transplant Infectious Disease

Volumn 4, Issue 4, 2002, Pages 226-227

  Marino, Ignacio R ^a,b   Panarello, G ^a   Singh, N ^c,d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; GALACTOMANNAN;

ASPERGILLOSIS; ASPERGILLUS; BLOOD LEVEL; CARBOHYDRATE ANALYSIS; CHEMOPROPHYLAXIS; EARLY DIAGNOSIS; HUMAN; LETTER; PRIORITY JOURNAL; TRANSPLANTATION;

EID: 0036966931     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3062.2002.02003.x     Document Type: Letter

References (3)

1. RUBIN RH. The therapeutic prescription for the transplant patient. Transpl Infect Dis 2002: 4: 1-2.
2. SINGH N, PATERSON D, GAYOWSKI T, WAGENER M, MARINO IR. Preemptive prophylaxis with a lipid preparation of amphotericin B for invasive fungal infections in liver transplant recipients requiring replacement therapy. Transplantation 2001: 71: 910-913.
3. BADEN LR, RUBIN RH. Fever, neutropenia, and the second law of thermodynamics. Ann Intern Medical 2002: 137: 123-124.